Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes
Year: 2006
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetologia
Institutions: Helsinki University Hospital, Novartis (Switzerland)
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: Novartis Pharma
OpenAlex ID: W2152978153
